Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal
Abstract
: Rebamipide was initially developed and approved for use in treating gastric ulcers and lesions associated with gastritis. Discovery of its ability to increase gastric mucin led to investigations of its effect on ocular surface mucin and the subsequent development for use in dry eye patients. Investigations have confirmed that rebamipide increases corneal and conjunctival mucin-like substances along with improving corneal and conjunctival...
Paper Details
Title
Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal
Published Date
May 1, 2014
Journal
Pages
1003 - 1003
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History